ARDELYX, INC. Cash Equivalents, at Carrying Value
ARDELYX, INC. (ARDX) had Cash Equivalents, at Carrying Value of $91.75 million as of 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2018-08-07
- 2018-06-30: Cash Equivalents, at Carrying Value $91.75M.
- 2018-03-31: Cash Equivalents, at Carrying Value $67.75M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2018-06-30 | $91.75M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $67.75M 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |